Nutex Health Inc.
NUTX
$146.00
$0.730.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 479.95M | 292.00M | 275.93M | 258.77M | 247.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 479.95M | 292.00M | 275.93M | 258.77M | 247.65M |
| Cost of Revenue | 264.72M | 205.78M | 204.78M | 200.90M | 195.28M |
| Gross Profit | 215.23M | 86.22M | 71.15M | 57.87M | 52.37M |
| SG&A Expenses | 58.56M | 40.26M | 36.28M | 35.70M | 36.07M |
| Depreciation & Amortization | 18.97M | 18.37M | 18.15M | 17.78M | 17.59M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 342.24M | 264.42M | 259.21M | 254.38M | 248.94M |
| Operating Income | 137.71M | 27.58M | 16.72M | 4.39M | -1.29M |
| Income Before Tax | 109.75M | -29.54M | -31.82M | -40.81M | -48.49M |
| Income Tax Expenses | 14.48M | 2.87M | -2.06M | -3.77M | -5.07M |
| Earnings from Continuing Operations | 95.27 | -32.41 | -29.77 | -37.04 | -43.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -43.09M | -8.73M | -8.12M | -3.96M | -2.36M |
| Net Income | 52.18M | -41.13M | -37.89M | -41.00M | -45.79M |
| EBIT | 137.71M | 27.58M | 16.72M | 4.39M | -1.29M |
| EBITDA | 156.68M | 46.26M | 35.22M | 22.43M | 16.30M |
| EPS Basic | 9.96 | -9.37 | -8.90 | -9.62 | -10.73 |
| Normalized Basic EPS | 5.76 | -0.91 | -1.24 | -2.44 | -3.14 |
| EPS Diluted | 9.22 | -9.40 | -8.93 | -9.65 | -10.75 |
| Normalized Diluted EPS | 5.42 | -0.91 | -1.24 | -2.44 | -3.14 |
| Average Basic Shares Outstanding | 20.13M | 19.13M | 18.47M | 17.88M | 17.37M |
| Average Diluted Shares Outstanding | 20.47M | 19.13M | 18.47M | 17.88M | 17.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.92% | -1.17% | -1.27% | -3.98% | -5.87% |